For more information visit: www.biosciences.sonydadc.com
Unedited press release follows:
Sony DADC and Axela to develop smart consumables for real time multiplex immunoassays
Sony DADC and Axela today announced a collaboration to develop and manufacture smart consumables for the dotLab® mX detection system.
The dotLab® mX System uniquely combines automated flow processing with diffractive optics to enable real time detection of binding events and full characterization of biomarkers through sequential probing. This provides significant analytical advantages for multiplex assay development and routine analysis in clinical research and diagnostics. The resultant dynamic range and panel flexibility is unachievable with any other commercially available product.
Paul Smith, Axela’s COO said: “Axela products can have an important impact on healthcare by simplifying analysis and significantly cutting the time from sample acquisition to result. Uniquely leveraging real time and label free analysis, this assay platform provides access to new combinations of biomarkers. Partnering on these advanced consumables will accelerate our expansion from research markets into applied testing and diagnostics.”
“Sony DADC BioSciences is excited to translate its excellence in manufacturing microstructured polymer devices like optical discs to the production of the next generation of dotLab® sensors for label free detection of protein biomarkers, bacteria and viruses.” said Harald Kraushaar, VP at Sony DADC.
Jessica Melin, Sr. Manager Business Development and Sales North America commented: “Axela’s demand for high-quality consumables and our manufacturing capabilities are a perfect match. We provide a scalable manufacturing solution based on injection molding that reduces the number of manufacturing steps. Furthermore, our technology will deliver consumables that are compatible with a broader range of applications and instrument formats.”
Axela’s VP of Product Development and Manufacturing, Dr. Alex Izmailov said: “Pairing our innovative platforms with high performance consumables is the key to success. Sony DADC’s precision sensors in combination with the inherent self referencing properties of diffractive optics will make our system highly attractive not only for biomarker screening and assay development but also as the method of choice for robust, routine analysis.”
Axela’s automated platforms for multiplexed DNA, RNA and protein analysis are designed to greatly simplify biomarker testing in clinical research and diagnostics. dotLab® mX System provide low multiplex, real time detection using diffractive optics and Ziplex System deliver high multiplex, rapid analysis using Flow-Thru Chips®. These approaches significantly improve the amount and quality of information when compared to traditional assays and provide access to unique categories of markers that form a pipeline of future diagnostic offerings. Toronto based Axela develops research products for sale through life science distributors, and partners with diagnostic companies for clinical tests. For information, visit www.axela.com.
About Sony DADC
Sony DADC is a leading disc and digital service provider for the entertainment, education and information industries, offering world-class digital and physical supply chain solutions and software services. Building on the company’s experience in high-precision manufacturing, its mass production capability and supply chain expertise, Sony DADC’s BioSciences division partners with Life Sciences and Diagnostics companies enabling the industrial manufacturing of smart consumables. Sony DADC’s global set-up comprises production sites, distribution hubs, digital & service facilities in 19 countries worldwide, including Japan, the US and Europe. For more information please visit www.biosciences.sonydadc.com.